Picture of Astria Therapeutics logo

ATXS — Astria Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Astria Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

* Astria Therapeutics Inc  ATXS.OQ  reported a quarterly
adjusted
loss of 38 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -40 cents.  The mean expectation of
five analysts for the quarter was for a loss of 36 cents per
share. Wall Street expected results to range from -41 cents
to -31 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Astria Therapeutics Inc's reported EPS for the quarter was
a
loss of 38 cents​.
    * The company reported a quarterly loss of $19.93 million.
    * Astria Therapeutics Inc shares had fallen by 32.0% this
quarter and gained 24.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 34.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Astria
Therapeutics Inc is $25.00 
This summary was machine generated from LSEG data May 9 at 09:37
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.36          -0.38          Missed
 Dec. 31 2023      -0.78          -0.94          Missed
 Sep. 30 2023      -0.49          -0.63          Missed
 Jun. 30 2023      -0.49          -0.45          Beat

Recent news on Astria Therapeutics

See all news